A large and apprently artificial collection of diverse kinetoplastid protein kinases. A subfamily has 2TM regions, but the majority is cytoplasmic.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 2 |
Pissara et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 30 |
NetGPI | no | yes: 0, no: 30 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0005634 | nucleus | 5 | 3 |
GO:0005737 | cytoplasm | 2 | 3 |
GO:0005829 | cytosol | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0005654 | nucleoplasm | 2 | 1 |
Related structures:
AlphaFold database: E9AWZ0
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 31 |
GO:0006793 | phosphorus metabolic process | 3 | 31 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 31 |
GO:0006807 | nitrogen compound metabolic process | 2 | 31 |
GO:0008152 | metabolic process | 1 | 31 |
GO:0009987 | cellular process | 1 | 31 |
GO:0016310 | phosphorylation | 5 | 31 |
GO:0019538 | protein metabolic process | 3 | 31 |
GO:0036211 | protein modification process | 4 | 31 |
GO:0043170 | macromolecule metabolic process | 3 | 31 |
GO:0043412 | macromolecule modification | 4 | 31 |
GO:0044237 | cellular metabolic process | 2 | 31 |
GO:0044238 | primary metabolic process | 2 | 31 |
GO:0071704 | organic substance metabolic process | 2 | 31 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 31 |
GO:0000281 | mitotic cytokinesis | 4 | 1 |
GO:0000910 | cytokinesis | 3 | 1 |
GO:0007165 | signal transduction | 2 | 4 |
GO:0022402 | cell cycle process | 2 | 1 |
GO:0035556 | intracellular signal transduction | 3 | 3 |
GO:0050789 | regulation of biological process | 2 | 4 |
GO:0050794 | regulation of cellular process | 3 | 4 |
GO:0061640 | cytoskeleton-dependent cytokinesis | 4 | 1 |
GO:0065007 | biological regulation | 1 | 4 |
GO:1903047 | mitotic cell cycle process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 31 |
GO:0003824 | catalytic activity | 1 | 31 |
GO:0004672 | protein kinase activity | 3 | 31 |
GO:0005488 | binding | 1 | 31 |
GO:0005524 | ATP binding | 5 | 31 |
GO:0016301 | kinase activity | 4 | 31 |
GO:0016740 | transferase activity | 2 | 31 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 31 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 31 |
GO:0017076 | purine nucleotide binding | 4 | 31 |
GO:0030554 | adenyl nucleotide binding | 5 | 31 |
GO:0032553 | ribonucleotide binding | 3 | 31 |
GO:0032555 | purine ribonucleotide binding | 4 | 31 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 31 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 31 |
GO:0036094 | small molecule binding | 2 | 31 |
GO:0043167 | ion binding | 2 | 31 |
GO:0043168 | anion binding | 3 | 31 |
GO:0097159 | organic cyclic compound binding | 2 | 31 |
GO:0097367 | carbohydrate derivative binding | 2 | 31 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 31 |
GO:1901265 | nucleoside phosphate binding | 3 | 31 |
GO:1901363 | heterocyclic compound binding | 2 | 31 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 14 |
GO:0106310 | protein serine kinase activity | 4 | 1 |
GO:0004707 | MAP kinase activity | 5 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 248 | 252 | PF00656 | 0.552 |
CLV_C14_Caspase3-7 | 506 | 510 | PF00656 | 0.264 |
CLV_NRD_NRD_1 | 135 | 137 | PF00675 | 0.552 |
CLV_NRD_NRD_1 | 163 | 165 | PF00675 | 0.584 |
CLV_NRD_NRD_1 | 241 | 243 | PF00675 | 0.638 |
CLV_NRD_NRD_1 | 326 | 328 | PF00675 | 0.286 |
CLV_NRD_NRD_1 | 484 | 486 | PF00675 | 0.301 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.472 |
CLV_PCSK_KEX2_1 | 134 | 136 | PF00082 | 0.582 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.587 |
CLV_PCSK_KEX2_1 | 227 | 229 | PF00082 | 0.545 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.400 |
CLV_PCSK_KEX2_1 | 241 | 243 | PF00082 | 0.644 |
CLV_PCSK_KEX2_1 | 326 | 328 | PF00082 | 0.210 |
CLV_PCSK_KEX2_1 | 484 | 486 | PF00082 | 0.297 |
CLV_PCSK_KEX2_1 | 586 | 588 | PF00082 | 0.383 |
CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.558 |
CLV_PCSK_PC1ET2_1 | 134 | 136 | PF00082 | 0.582 |
CLV_PCSK_PC1ET2_1 | 227 | 229 | PF00082 | 0.548 |
CLV_PCSK_PC1ET2_1 | 24 | 26 | PF00082 | 0.387 |
CLV_PCSK_PC1ET2_1 | 586 | 588 | PF00082 | 0.299 |
CLV_PCSK_PC1ET2_1 | 98 | 100 | PF00082 | 0.558 |
CLV_PCSK_PC7_1 | 582 | 588 | PF00082 | 0.291 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.531 |
CLV_PCSK_SKI1_1 | 361 | 365 | PF00082 | 0.294 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.394 |
CLV_PCSK_SKI1_1 | 422 | 426 | PF00082 | 0.303 |
CLV_PCSK_SKI1_1 | 454 | 458 | PF00082 | 0.362 |
CLV_PCSK_SKI1_1 | 484 | 488 | PF00082 | 0.330 |
DEG_SPOP_SBC_1 | 196 | 200 | PF00917 | 0.545 |
DOC_CKS1_1 | 130 | 135 | PF01111 | 0.557 |
DOC_CKS1_1 | 260 | 265 | PF01111 | 0.543 |
DOC_CKS1_1 | 497 | 502 | PF01111 | 0.336 |
DOC_MAPK_gen_1 | 454 | 463 | PF00069 | 0.324 |
DOC_PP1_RVXF_1 | 392 | 399 | PF00149 | 0.262 |
DOC_PP1_RVXF_1 | 474 | 481 | PF00149 | 0.275 |
DOC_PP4_FxxP_1 | 121 | 124 | PF00568 | 0.573 |
DOC_PP4_FxxP_1 | 233 | 236 | PF00568 | 0.519 |
DOC_USP7_MATH_1 | 183 | 187 | PF00917 | 0.621 |
DOC_USP7_MATH_1 | 284 | 288 | PF00917 | 0.534 |
DOC_USP7_MATH_1 | 345 | 349 | PF00917 | 0.267 |
DOC_USP7_MATH_1 | 59 | 63 | PF00917 | 0.553 |
DOC_USP7_MATH_1 | 65 | 69 | PF00917 | 0.572 |
DOC_USP7_MATH_2 | 124 | 130 | PF00917 | 0.542 |
DOC_USP7_UBL2_3 | 53 | 57 | PF12436 | 0.499 |
DOC_USP7_UBL2_3 | 93 | 97 | PF12436 | 0.540 |
DOC_WW_Pin1_4 | 104 | 109 | PF00397 | 0.559 |
DOC_WW_Pin1_4 | 112 | 117 | PF00397 | 0.549 |
DOC_WW_Pin1_4 | 129 | 134 | PF00397 | 0.648 |
DOC_WW_Pin1_4 | 179 | 184 | PF00397 | 0.531 |
DOC_WW_Pin1_4 | 259 | 264 | PF00397 | 0.573 |
DOC_WW_Pin1_4 | 302 | 307 | PF00397 | 0.501 |
DOC_WW_Pin1_4 | 496 | 501 | PF00397 | 0.343 |
DOC_WW_Pin1_4 | 566 | 571 | PF00397 | 0.258 |
LIG_14-3-3_CanoR_1 | 135 | 140 | PF00244 | 0.553 |
LIG_14-3-3_CanoR_1 | 228 | 234 | PF00244 | 0.590 |
LIG_14-3-3_CanoR_1 | 246 | 255 | PF00244 | 0.523 |
LIG_14-3-3_CanoR_1 | 433 | 440 | PF00244 | 0.274 |
LIG_APCC_ABBA_1 | 405 | 410 | PF00400 | 0.267 |
LIG_BIR_III_4 | 509 | 513 | PF00653 | 0.264 |
LIG_BRCT_BRCA1_1 | 25 | 29 | PF00533 | 0.404 |
LIG_EVH1_2 | 229 | 233 | PF00568 | 0.549 |
LIG_FHA_1 | 230 | 236 | PF00498 | 0.562 |
LIG_FHA_1 | 297 | 303 | PF00498 | 0.583 |
LIG_FHA_1 | 362 | 368 | PF00498 | 0.451 |
LIG_FHA_1 | 434 | 440 | PF00498 | 0.251 |
LIG_FHA_1 | 485 | 491 | PF00498 | 0.303 |
LIG_FHA_2 | 246 | 252 | PF00498 | 0.568 |
LIG_FHA_2 | 463 | 469 | PF00498 | 0.346 |
LIG_FHA_2 | 527 | 533 | PF00498 | 0.288 |
LIG_LIR_Apic_2 | 120 | 124 | PF02991 | 0.574 |
LIG_LIR_Apic_2 | 231 | 236 | PF02991 | 0.520 |
LIG_LIR_Apic_2 | 499 | 505 | PF02991 | 0.331 |
LIG_LIR_Gen_1 | 299 | 309 | PF02991 | 0.445 |
LIG_LIR_Gen_1 | 346 | 357 | PF02991 | 0.390 |
LIG_LIR_Nem_3 | 299 | 304 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 335 | 339 | PF02991 | 0.355 |
LIG_LIR_Nem_3 | 346 | 352 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 392 | 396 | PF02991 | 0.342 |
LIG_SH2_CRK | 336 | 340 | PF00017 | 0.309 |
LIG_SH2_SRC | 445 | 448 | PF00017 | 0.288 |
LIG_SH2_STAP1 | 298 | 302 | PF00017 | 0.443 |
LIG_SH2_STAP1 | 517 | 521 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 298 | 301 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 340 | 343 | PF00017 | 0.323 |
LIG_SH2_STAT5 | 397 | 400 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 411 | 414 | PF00017 | 0.392 |
LIG_SH2_STAT5 | 445 | 448 | PF00017 | 0.327 |
LIG_SH3_1 | 423 | 429 | PF00018 | 0.245 |
LIG_SH3_2 | 538 | 543 | PF14604 | 0.311 |
LIG_SH3_3 | 103 | 109 | PF00018 | 0.561 |
LIG_SH3_3 | 217 | 223 | PF00018 | 0.627 |
LIG_SH3_3 | 257 | 263 | PF00018 | 0.575 |
LIG_SH3_3 | 423 | 429 | PF00018 | 0.313 |
LIG_SH3_3 | 535 | 541 | PF00018 | 0.315 |
LIG_SH3_3 | 58 | 64 | PF00018 | 0.522 |
LIG_SH3_3 | 71 | 77 | PF00018 | 0.517 |
LIG_Sin3_3 | 41 | 48 | PF02671 | 0.431 |
LIG_SUMO_SIM_par_1 | 371 | 376 | PF11976 | 0.275 |
LIG_TRAF2_1 | 200 | 203 | PF00917 | 0.543 |
LIG_TRAF2_1 | 291 | 294 | PF00917 | 0.470 |
LIG_TRAF2_1 | 564 | 567 | PF00917 | 0.267 |
LIG_WRC_WIRS_1 | 390 | 395 | PF05994 | 0.267 |
MOD_CDK_SPK_2 | 129 | 134 | PF00069 | 0.577 |
MOD_CDK_SPxK_1 | 129 | 135 | PF00069 | 0.567 |
MOD_CDK_SPxxK_3 | 129 | 136 | PF00069 | 0.555 |
MOD_CK1_1 | 125 | 131 | PF00069 | 0.583 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.551 |
MOD_CK1_1 | 259 | 265 | PF00069 | 0.556 |
MOD_CK1_1 | 317 | 323 | PF00069 | 0.446 |
MOD_CK1_1 | 491 | 497 | PF00069 | 0.299 |
MOD_CK1_1 | 515 | 521 | PF00069 | 0.363 |
MOD_CK2_1 | 114 | 120 | PF00069 | 0.576 |
MOD_CK2_1 | 175 | 181 | PF00069 | 0.520 |
MOD_CK2_1 | 197 | 203 | PF00069 | 0.586 |
MOD_CK2_1 | 288 | 294 | PF00069 | 0.482 |
MOD_CK2_1 | 526 | 532 | PF00069 | 0.265 |
MOD_GlcNHglycan | 100 | 103 | PF01048 | 0.565 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.516 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.581 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.547 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.579 |
MOD_GlcNHglycan | 290 | 293 | PF01048 | 0.495 |
MOD_GlcNHglycan | 417 | 420 | PF01048 | 0.278 |
MOD_GlcNHglycan | 440 | 443 | PF01048 | 0.373 |
MOD_GlcNHglycan | 509 | 513 | PF01048 | 0.314 |
MOD_GlcNHglycan | 514 | 517 | PF01048 | 0.399 |
MOD_GlcNHglycan | 544 | 547 | PF01048 | 0.302 |
MOD_GlcNHglycan | 554 | 557 | PF01048 | 0.361 |
MOD_GlcNHglycan | 67 | 70 | PF01048 | 0.577 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.638 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.532 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.546 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.534 |
MOD_GSK3_1 | 264 | 271 | PF00069 | 0.579 |
MOD_GSK3_1 | 284 | 291 | PF00069 | 0.593 |
MOD_GSK3_1 | 296 | 303 | PF00069 | 0.438 |
MOD_GSK3_1 | 313 | 320 | PF00069 | 0.335 |
MOD_GSK3_1 | 397 | 404 | PF00069 | 0.286 |
MOD_GSK3_1 | 427 | 434 | PF00069 | 0.245 |
MOD_GSK3_1 | 484 | 491 | PF00069 | 0.329 |
MOD_GSK3_1 | 492 | 499 | PF00069 | 0.363 |
MOD_GSK3_1 | 508 | 515 | PF00069 | 0.364 |
MOD_GSK3_1 | 522 | 529 | PF00069 | 0.352 |
MOD_GSK3_1 | 554 | 561 | PF00069 | 0.314 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.565 |
MOD_N-GLC_1 | 317 | 322 | PF02516 | 0.388 |
MOD_N-GLC_2 | 389 | 391 | PF02516 | 0.267 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.401 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.517 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.624 |
MOD_NEK2_1 | 313 | 318 | PF00069 | 0.422 |
MOD_NEK2_1 | 462 | 467 | PF00069 | 0.313 |
MOD_NEK2_1 | 552 | 557 | PF00069 | 0.311 |
MOD_NEK2_2 | 284 | 289 | PF00069 | 0.496 |
MOD_NEK2_2 | 345 | 350 | PF00069 | 0.287 |
MOD_NEK2_2 | 82 | 87 | PF00069 | 0.533 |
MOD_PIKK_1 | 198 | 204 | PF00454 | 0.534 |
MOD_PIKK_1 | 268 | 274 | PF00454 | 0.540 |
MOD_PIKK_1 | 433 | 439 | PF00454 | 0.334 |
MOD_PIKK_1 | 445 | 451 | PF00454 | 0.229 |
MOD_PIKK_1 | 468 | 474 | PF00454 | 0.292 |
MOD_PIKK_1 | 488 | 494 | PF00454 | 0.384 |
MOD_PK_1 | 256 | 262 | PF00069 | 0.545 |
MOD_PKA_1 | 135 | 141 | PF00069 | 0.542 |
MOD_PKA_1 | 326 | 332 | PF00069 | 0.232 |
MOD_PKA_1 | 484 | 490 | PF00069 | 0.267 |
MOD_PKA_1 | 586 | 592 | PF00069 | 0.363 |
MOD_PKA_1 | 97 | 103 | PF00069 | 0.563 |
MOD_PKA_2 | 135 | 141 | PF00069 | 0.553 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.642 |
MOD_PKA_2 | 245 | 251 | PF00069 | 0.499 |
MOD_PKA_2 | 288 | 294 | PF00069 | 0.517 |
MOD_PKA_2 | 326 | 332 | PF00069 | 0.240 |
MOD_PKA_2 | 484 | 490 | PF00069 | 0.301 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.463 |
MOD_PKA_2 | 586 | 592 | PF00069 | 0.345 |
MOD_PKA_2 | 98 | 104 | PF00069 | 0.565 |
MOD_Plk_1 | 125 | 131 | PF00069 | 0.542 |
MOD_Plk_1 | 151 | 157 | PF00069 | 0.534 |
MOD_Plk_4 | 326 | 332 | PF00069 | 0.258 |
MOD_Plk_4 | 335 | 341 | PF00069 | 0.319 |
MOD_Plk_4 | 427 | 433 | PF00069 | 0.301 |
MOD_Plk_4 | 492 | 498 | PF00069 | 0.300 |
MOD_ProDKin_1 | 104 | 110 | PF00069 | 0.555 |
MOD_ProDKin_1 | 112 | 118 | PF00069 | 0.549 |
MOD_ProDKin_1 | 129 | 135 | PF00069 | 0.652 |
MOD_ProDKin_1 | 179 | 185 | PF00069 | 0.532 |
MOD_ProDKin_1 | 259 | 265 | PF00069 | 0.574 |
MOD_ProDKin_1 | 302 | 308 | PF00069 | 0.500 |
MOD_ProDKin_1 | 496 | 502 | PF00069 | 0.343 |
MOD_ProDKin_1 | 566 | 572 | PF00069 | 0.258 |
MOD_SUMO_for_1 | 601 | 604 | PF00179 | 0.409 |
MOD_SUMO_rev_2 | 251 | 258 | PF00179 | 0.533 |
MOD_SUMO_rev_2 | 90 | 100 | PF00179 | 0.517 |
TRG_ENDOCYTIC_2 | 336 | 339 | PF00928 | 0.335 |
TRG_ENDOCYTIC_2 | 340 | 343 | PF00928 | 0.339 |
TRG_ER_diArg_1 | 163 | 165 | PF00400 | 0.584 |
TRG_ER_diArg_1 | 240 | 242 | PF00400 | 0.639 |
TRG_ER_diArg_1 | 325 | 327 | PF00400 | 0.354 |
TRG_ER_diArg_1 | 484 | 486 | PF00400 | 0.308 |
TRG_NES_CRM1_1 | 365 | 378 | PF08389 | 0.290 |
TRG_NLS_MonoExtC_3 | 421 | 426 | PF00514 | 0.293 |
TRG_NLS_MonoExtN_4 | 133 | 138 | PF00514 | 0.546 |
TRG_Pf-PMV_PEXEL_1 | 163 | 167 | PF00026 | 0.516 |
TRG_Pf-PMV_PEXEL_1 | 484 | 488 | PF00026 | 0.267 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTF0 | Leptomonas seymouri | 60% | 96% |
A0A3Q8ICW9 | Leishmania donovani | 91% | 100% |
A0A3Q8IH39 | Leishmania donovani | 21% | 100% |
A0A3Q8ITZ9 | Leishmania donovani | 25% | 100% |
A0A3Q8IVR8 | Leishmania donovani | 25% | 100% |
A0A3S5H5G0 | Leishmania donovani | 25% | 100% |
A4H459 | Leishmania braziliensis | 25% | 100% |
A4H601 | Leishmania braziliensis | 22% | 100% |
A4H9U7 | Leishmania braziliensis | 23% | 100% |
A4HDJ5 | Leishmania braziliensis | 80% | 100% |
A4HFA1 | Leishmania braziliensis | 26% | 100% |
A4HLJ9 | Leishmania braziliensis | 25% | 100% |
A4HNT2 | Leishmania braziliensis | 24% | 100% |
A4HSE2 | Leishmania infantum | 25% | 100% |
A4HUC8 | Leishmania infantum | 21% | 100% |
A4I0Y4 | Leishmania infantum | 91% | 100% |
A4I910 | Leishmania infantum | 25% | 100% |
A4ICR2 | Leishmania infantum | 25% | 100% |
C9ZL78 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
E9AJJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9AKB7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9AN28 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 21% | 100% |
E9ASJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9B3X5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
Q4Q204 | Leishmania major | 25% | 100% |
Q4Q449 | Leishmania major | 25% | 100% |
Q4QAI6 | Leishmania major | 89% | 99% |
Q4QHJ8 | Leishmania major | 21% | 100% |
Q4QJJ0 | Leishmania major | 25% | 100% |